z-logo
open-access-imgOpen Access
CUX2 functions as an oncogene in papillary thyroid cancer
Author(s) -
Yihan Sun,
Danrong Ye,
Yuefeng Li,
Endong Chen,
Rutian Hao,
Yefeng Cai,
Qingxuan Wang,
Ouchen Wang,
Xiaohua Zhang
Publication year - 2018
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s185710
Subject(s) - oncogene , cancer research , pi3k/akt/mtor pathway , papillary thyroid cancer , thyroid cancer , gene silencing , thyroid carcinoma , cancer , medicine , thyroid function , malignancy , protein kinase b , oncology , thyroid , biology , apoptosis , genetics , cell cycle , gene
In recent years, the incidence of thyroid cancer (TC), the most common endocrine malignancy, has been increasing. Emerging evidence indicates that the CUT/CUX/CDP family of proteins can play an important role in tumor development and progression by regulating many cancer-related functions. However, the molecular functions of CUX2 in TC remain unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here